Halstenbek, Germany

Andreas Scheel

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Hamburg, DE (2013)
  • Halstenbek, DE (2014 - 2015)

Company Filing History:


Years Active: 2013-2015

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Andreas Scheel: Innovator in Kynurenine-3-Monooxygenase Inhibitors

Introduction

Andreas Scheel is a notable inventor based in Halstenbek, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of kynurenine-3-monooxygenase (KMO) inhibitors. With a total of 3 patents to his name, Scheel's work focuses on innovative methods for treating neurodegenerative disorders.

Latest Patents

Scheel's latest patents include advancements in certain kynurenine-3-monooxygenase inhibitors and their pharmaceutical compositions. These patents describe chemical entities that can be used to treat patients suffering from diseases responsive to KMO activity inhibition. The methods outlined in his patents involve administering effective amounts of these chemical entities to reduce the signs or symptoms of disorders such as Huntington's disease. Additionally, the patents detail methods for screening compounds capable of inhibiting KMO activity, showcasing the potential for further research and development in this area.

Career Highlights

Andreas Scheel is currently associated with the CHDI Foundation, Inc., where he continues to advance his research in the pharmaceutical field. His work is pivotal in developing treatments that target neurodegenerative diseases, contributing to the broader understanding of KMO's role in these conditions.

Collaborations

Scheel collaborates with esteemed colleagues, including John Wityak and Leticia M. Toledo-Sherman. Their combined expertise enhances the research efforts at the CHDI Foundation, fostering innovation in the treatment of complex diseases.

Conclusion

Andreas Scheel's contributions to the field of pharmaceuticals, particularly through his patents on kynurenine-3-monooxygenase inhibitors, highlight his role as an influential inventor. His work not only addresses critical health issues but also paves the way for future advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…